Daniel Loeb
Third Point
Third Point Portfolio 13F
Daniel Loeb Holdings Activity
- Portfolio value:
- $4.08B≈ (-$319M≈)
- Previous value:
- $4.40B≈
- # of changes:
- 31
- New positions:
- 11
- Reported for:
- 30 Sep 2013 (Q3)
- Latest filing date:
- 19 Nov 2013
Third Point has disclosed a total of 31 changes to the portfolio in the (2013 Q3) SEC report(s): increased the number of shares of 6, bought 11 totally new, decreased the number of shares of 11 and completely sold out 3 position(s).
What stocks did Daniel Loeb buy in 2013 Q3?
During 2013 Q3 Daniel Loeb has bought 17 securities out of which top 5 purchases (by % change to portfolio) were (BID) Sotheby's (added shares +146.00%), (FDX) FedEx Corp (new buy), (CF) CF Industries Holdings Inc (added shares +2.96%), (STZ) Constellation Brands Inc, CL-A (added shares +83.33%) and (ELN) ELAN CORP PLC -SPONS ADR (added shares +17.65%).
Warning: SEC insider reports detected for Third Point (real-time trades and ownership disclosures)
1 ownership disclosure as of 3 months ago
31 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Precigen Inc
|
new
|
$22.84
|
-70.52%($6.74)
|
1.20%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
QVC GROUP INC
|
new
|
$23.47
|
|
0.72%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
Nielsen Holdings PLC
|
new
|
$36.45
|
|
0.89%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
Nokia Corp ADR
|
new
|
$6.51
|
+49.10%($9.70)
|
0.32%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
Activision Blizzard Inc
|
new
|
$16.68
|
|
1.06%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
CYTEC INDUSTRIES INC
|
new
|
$81.36
|
|
0.14%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
EQT Corp
|
new
|
$88.72
|
-42.13%($51.34)
|
2.17%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
FedEx Corp
|
new
|
$114.11
|
+172.72%($311.20)
|
5.59%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
FIDELITY NATIONAL FINANCIAL
|
new
|
$26.60
|
|
1.37%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
Gilead Sciences Inc
|
new
|
$62.87
|
+107.36%($130.37)
|
0.77%
|
2013 Q3
|
≈ 0.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.